Med. praxi. 2025;22(5):366-370 | DOI: 10.36290/med.2025.044

Myocarditis in the differential diagnosis of dyspnea

MUDr. Petra Appeltauerová, MUDr. Julius Godava, MUDr. Hana Poloczková, Ph.D., MUDr. Karel Lábr, Ph.D., prof. MUDr. Jan Krejčí, Ph.D., FHFA
I. interní kardioangiologická klinika Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity v Brně

Myocarditis is an inflammatory disease of the heart muscle that can have infectious (most commonly viral) or non-infectious origins, including autoimmune or toxic causes. The disease is characterized by a wide spectrum of clinical manifestations, ranging from a subclinical course to fulminant forms ending in acute heart failure or sudden cardiac death. Diagnosis requires a comprehensive approach, including history, laboratory tests, imaging, and in some cases, endomyocardial biopsy. Treatment depends on the severity of the course and may include targeted immunosuppression or antiviral therapy in addition to symptomatic therapy and treatment of heart failure. This text provides an overview of current knowledge on the etiology, diagnosis, and treatment of myocarditis. It highlights the risk factors in the patient's history, the symptoms with which patients often present to the general practitioner, and the investigative methods that are available in the general practitioner's office. A complementary clinical case report of a young patient with breathing difficulties highlights why it is necessary to think about this disease and refer the patient to a specialist department for investigation.

Keywords: shortness of breath, chest pain, myocarditis, inflammatory cardiomyopathy, dilated cardiomyopathy, heart failure, differential diagnosis, cMR (cardiac magnetic resonance), endomyocardial biopsy, viral infection.

Received: May 16, 2025; Accepted: May 19, 2025; Published: December 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Appeltauerová P, Godava J, Poloczková H, Lábr K, Krejčí FHFA J. Myocarditis in the differential diagnosis of dyspnea. Med. praxi. 2025;22(5):366-370. doi: 10.36290/med.2025.044.
Download citation

References

  1. Writing Committee; Drazner MH, Bozkurt B, Cooper LT, et al. 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2025 Feb 4;85(4):391-431. doi: 10.1016/j.jacc.2024.10.080. Epub 2024 Dec 10. PMID: 39665703. Go to original source... Go to PubMed...
  2. Ammirati E, Frigerio M, Adler ED, et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12. PMID: 33176455; PMCID: PMC7673642. Go to original source... Go to PubMed...
  3. Nagai T, Inomata T, Kohno Tet al; Japanese Circulation Society Joint Working Group. JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis. Circ J. 2023 Apr 25;87(5):674-754. doi: 10.1253/circj.CJ-22-0696. Epub 2023 Mar 31. PMID: 36908170. Go to original source... Go to PubMed...
  4. Krejčí J. Myokarditidy. In: Táborský M, Kautzner J, Linhart A, eds. Kardiologie. Svazek VII. 1. vydání. Praha: EEZY Publishing; 2024. ISBN: 978-80-88506-26-3.
  5. Vojáček J, Kettner J. Klinická kardiologie. 5. vydání. Jessenius. Praha: Maxdorf; 2022. ISBN 978-80-7345-744-0.
  6. Joudar I, Aichouni N, Nasri S, et al. Diagnostic criteria for myocarditis on cardiac magnetic resonance imaging: an educational review. Ann Med Surg (Lond). 2023 Jul 6;85(8):3960-3964. doi: 10.1097/MS9.0000000000001040. PMID: 37554854; PMCID: PMC10406012. Go to original source... Go to PubMed...
  7. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018 Dec 18;72(24):3158-3176. doi: 10.1016/j.jacc.2018.09.072. PMID: 30545455. Go to original source... Go to PubMed...
  8. Caforio AL, Pankuweit S, Arbustini E, et al; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3. PMID: 23824828. Go to original source... Go to PubMed...
  9. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195. Erratum in: Eur Heart J. 2024 Jan 1;45(1):53. doi: 10.1093/eurheartj/ehad613. PMID: 37622666. Go to original source... Go to PubMed...
  10. Arbelo E, Protonotarios A, Gimeno JR, et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194. PMID: 37622657. Go to original source... Go to PubMed...
  11. Poloczková H, Honek T, Chaloupka A, et al. Novinky v diagnostice a léčbě kardiomyopatií. Vnitr Lek. 2023;69(2):89-104. doi: 10.36290/vnl.2023.016. Go to original source... Go to PubMed...
  12. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000 Nov 9;343(19):1388-98. doi: 10.1056/NEJM200011093431908. PMID: 11070105. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.